London
· Delayed Price · Currency is GBP · Price in SEK Surgical Science Sweden AB Statistics
Total Valuation
Surgical Science Sweden AB has a market cap or net worth of GBP 642.16 million. The enterprise value is 593.66 million.
| Market Cap | 642.16M |
| Enterprise Value | 593.66M |
Important Dates
The next estimated earnings date is Wednesday, February 19, 2025.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 37.43M |
Valuation Ratios
The trailing PE ratio is 45.15.
| PE Ratio | 45.15 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 10.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 43.81, with an EV/FCF ratio of 72.66.
| EV / Earnings | 41.74 |
| EV / Sales | 9.49 |
| EV / EBITDA | 43.81 |
| EV / EBIT | 56.26 |
| EV / FCF | 72.66 |
Financial Position
The company has a current ratio of 4.44
| Current Ratio | 4.44 |
| Quick Ratio | 3.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.31% and return on invested capital (ROIC) is 2.02%.
| Return on Equity (ROE) | 4.31% |
| Return on Assets (ROA) | 1.86% |
| Return on Invested Capital (ROIC) | 2.02% |
| Return on Capital Employed (ROCE) | 3.18% |
| Revenue Per Employee | 234,265 |
| Profits Per Employee | 52,677 |
| Employee Count | 260 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.13% in the last 52 weeks. The beta is 0.97, so Surgical Science Sweden AB's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -5.13% |
| 50-Day Moving Average | 152.39 |
| 200-Day Moving Average | 139.86 |
| Relative Strength Index (RSI) | 57.82 |
| Average Volume (20 Days) | 7,803 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Surgical Science Sweden AB had revenue of GBP 63.25 million and earned 14.22 million in profits. Earnings per share was 0.28.
| Revenue | 63.25M |
| Gross Profit | 43.42M |
| Operating Income | 10.67M |
| Pretax Income | 17.44M |
| Net Income | 14.22M |
| EBITDA | 12.60M |
| EBIT | 10.67M |
| Earnings Per Share (EPS) | 0.28 |
Balance Sheet
| Cash & Cash Equivalents | 49.02M |
| Total Debt | n/a |
| Net Cash | 49.02M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 327.29M |
| Book Value Per Share | 6.41 |
| Working Capital | 61.70M |
Cash Flow
In the last 12 months, operating cash flow was 8.84 million and capital expenditures -667,731, giving a free cash flow of 8.17 million.
| Operating Cash Flow | 8.84M |
| Capital Expenditures | -667,731 |
| Free Cash Flow | 8.17M |
| FCF Per Share | n/a |
Margins
Gross margin is 68.65%, with operating and profit margins of 16.86% and 22.49%.
| Gross Margin | 68.65% |
| Operating Margin | 16.86% |
| Pretax Margin | 27.58% |
| Profit Margin | 22.49% |
| EBITDA Margin | 19.92% |
| EBIT Margin | 16.86% |
| FCF Margin | 12.92% |
Dividends & Yields
Surgical Science Sweden AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.26% |
| Earnings Yield | 2.21% |
| FCF Yield | 1.27% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Surgical Science Sweden AB has an Altman Z-Score of 13.37.
| Altman Z-Score | 13.37 |
| Piotroski F-Score | n/a |